Concepedia

Author

Lawrence A. Leiter

St. Michael's HospitalORCID

Also Known As

Alan Kelly, Cristina-Dana Calciu, D. Kilby, E Jovanovski, Fulcher, Gregory R., Harpreet S. Bajaj, Hua, Tsushung A., Ivo Petrov, L A Leiter, L LEITER

871

Publications

88.8K

Citations

136

H-Index

207

Concepts

All Affiliations

St. Michael's HospitalUniversity of TorontoBrigham and Women's HospitalThe University of Texas Southwestern Medical CenterHarvard University
LA

About

Lawrence A. Leiter is an author at St. Michael's Hospital specializing in medicine, public health, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

59

125

19.3K

2

Public Health

47

80

11.4K

3

Health Sciences

25

29

3.4K

4

Natural Sciences

1

1

229

5

Nursing

1

1

65

Lawrence A. Leiter

×

340

Publications

57.3K

Citations

108

H-Index

YearCitations

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca,

New England Journal of Medicine

2018

6K

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald,

New England Journal of Medicine

2013

3.4K

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais,

The Lancet

2019

2.8K

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt,

New England Journal of Medicine

2012

2K

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg,

New England Journal of Medicine

2020

1.7K

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed,

The Lancet

2018

1.7K

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray, R. Scott Wright, David Kallend,

New England Journal of Medicine

2020

1.4K

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Deepak L. Bhatt, Michael Szarek, Bertram Pitt,

New England Journal of Medicine

2020

1.1K

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter,

New England Journal of Medicine

2017

950

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

Salim Yusuf, Jackie Bosch, Gilles R. Dagenais,

New England Journal of Medicine

2016

827

Page 1